E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) with Acute Respiratory Failure in Three Adolescent Patients: a Clinical Timeline, Treatment, and Product Analysis
Journal of Medical Toxicology · 2020-07 · 16 (3) · 248-254
DOI: 10.1007/s13181-020-00765-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Medical Toxicology, online erschienen am 19.03.2020. Verfasst von Ramya Billa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
INTRODUCTION: E-cigarette, or vaping, product use associated lung injury (EVALI) has become a recent concern among public health officials. Factors that contribute to the concern include an increasing number of cases over time, the severity of the illness, and an unknown understanding of the pathophysiology and etiology of the illness. CASE SERIES: We cared for three adolescent patients with acute respiratory failure secondary to EVALI. All three patients were treated with high-dose steroids in addition to antimicrobials, which resulted in clinical improvement and resolution of their respiratory failure. Pulmonary function testing was performed on these previously healthy patients both acutely and subacutely. Additionally, we report the results from the laboratory analysis of one vaping device fluid which revealed previously unpublished components within these products. DISCUSSION: EVALI is a recent public health concern without a known etiology which can cause life-threatening lung injury in patients without prior lung pathology. We hope these cases will highlight the importance of return precautions in adolescents with vague respiratory symptoms and provide a cautionary tale to providers while they counsel patients regarding the use of these products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA, USA.
- Department of Emergency Medicine, University of Iowa, Iowa City, IA, USA.
- Iowa Department of Public Health, Des Moines, IA, USA.
- Department of Emergency Medicine, University of Iowa, Iowa City, IA, USA. daniel-j-mccabe@uiowa.edu.
ORCID-Profile: Daniel McCabe
Zitieren
APA
Billa, R., Tigges, C., Vijayakumar, N., Radke, J., Pedati, C., Weiner, R., & McCabe, D. (2020). E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) with Acute Respiratory Failure in Three Adolescent Patients: a Clinical Timeline, Treatment, and Product Analysis. Journal of Medical Toxicology, 16(3), 248-254. https://doi.org/10.1007/s13181-020-00765-9
Vancouver
Billa R, Tigges C, Vijayakumar N, Radke J, Pedati C, Weiner R, et al. E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) with Acute Respiratory Failure in Three Adolescent Patients: a Clinical Timeline, Treatment, and Product Analysis. Journal of Medical Toxicology. 2020;16(3):248-254. doi:10.1007/s13181-020-00765-9
BibTeX
@article{Billa2020,
author = {Billa, Ramya and Tigges, Cody and Vijayakumar, Niranjan and Radke, Joshua and Pedati, Caitlin and Weiner, Rebecca and McCabe, Daniel},
title = {E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) with Acute Respiratory Failure in Three Adolescent Patients: a Clinical Timeline, Treatment, and Product Analysis},
journal = {Journal of Medical Toxicology},
year = {2020},
volume = {16},
number = {3},
pages = {248--254},
doi = {10.1007/s13181-020-00765-9}
}
EUVIMED